Veonet

{{Short description|European ophthalmology company}}

{{Use dmy dates|date= January 2025}}

{{Use British English|date= January 2025}}

Veonet is a European company operating 210 ophthalmology clinics, {{as of|2022|11|lc=y}}.{{Cite web |last=Miranza |first=Equipo |date=2022-09-13 |title=Miranza joins the veonet European network of ophthalmology groups |url=https://miranza.es/en/news/miranza-joins-veonet-a-european-network-of-ophthalmology-groups/ |access-date=2025-01-31 |website=Miranza |language=en-US}}

Veonet has its headquarters in Munich, Germany, and operates clinics in Germany, the UK, the Netherlands, Switzerland, and Spain.{{Cite web |title=Nordic Capital agrees to sell Veonet to Ontario Teachers’ and PAI Partners |url=https://www.nordiccapital.com/news-views/press-releases/nordic-capital-agrees-to-sell-veonet-to-ontario-teachers-and-pai-partners/ |access-date=2025-01-31 |website=Nordic Capital |language=en-GB}} Veonet is owned by the private equity firm PAI Partners and the Ontario Teachers' Pension Plan, after they agreed to buy it from private equity firm Nordic Capital in December 2021.

In November 2024, Sebastian James succeeded Markus Hamm as CEO of Veonet.{{Cite web |title=Boots chief James to run ophthalmology chain Veonet |url=https://news.sky.com/story/boots-chief-james-to-run-ophthalmology-chain-veonet-13161258 |access-date=2025-01-31 |website=Sky News |language=en}}

Veoent owns the Ober Scharrer Gruppe (OSG) in Germany, SpaMedica in the UK, VISTA in Switzerland, Eyescan in the Netherlands and Miranza in Spain.